CBI’s 5th Annual Formulary, Copay and Access Summit

CBI’s 5th Annual Formulary, Copay and Access Summit April 9-11, 2019 | San Francisco, CA www.cbinet.com/formulary Accumulator programs, state-level copay legislation, formulary exclusions, high-deductible plans, changes in benefit design, NDC blocks, step therapy programs – the challenges continue to arise. This April, the industry comes together to tackle these topics and more at the Formulary, Copay and Access Summit in San Francisco. Visit www.cbinet.com/formulary for further details and to register. Drug Channels readers will save $300 off the standard rate when they use promo code KRA435 and register prior to March 22nd.* Download the agenda here and see in-depth coverage … Continue reading CBI’s 5th Annual Formulary, Copay and Access Summit

CBI’s 4th Edition Drug Pricing Transparency Congress

CBI’s 4th Edition Drug Pricing Transparency Congress March 25-26, 2019 | Philadelphia, PA www.cbinet.com/drugpricing From implementation and changes made across the country in states like Oregon, California and Nevada to the release of the long-awaited HHS proposed rebate rule, complexities continue to arise for industry. According to HHS Secretary Alex Azar, this proposal “has the potential to be the most significant change in how Americans’ drugs are priced at the pharmacy counter, ever.” With all that is going on with drug pricing within state and federal laws, uncertainty arises for stakeholders with responsibilities in commercialization, reimbursement, pricing and compliance practices. … Continue reading CBI’s 4th Edition Drug Pricing Transparency Congress

Pharmacy Fraud Within Pharmaceutical Co-Pay Programs: What You Need To Know

Today’s guest post comes from Tim Ogren, Senior Vice President, Products at TrialCard. Tim discusses the rise in pharmacies making fraudulent claims and the costs of these claims. Learn more in Trialcard’s white paper: Detecting Pharmacy Fraud: Is Your Brand’s Co-Pay Program Protected? TrialCard developed Spotlight®, a pharmacy fraud detection product for manufacturers. To learn more, contact Tim Ogren, TrialCard’s Senior Vice President of Products, at tim.ogren@trialcard.com. Read on for Tim’s insights. Read more » Copyright © 2006-2019 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. This Feed is for personal … Continue reading Pharmacy Fraud Within Pharmaceutical Co-Pay Programs: What You Need To Know

Expanded Access Programs 2019

Expanded Access Programs 2019 March 27-28, 2019 | The Inn at Penn | Philadelphia, PA www.cbinet.com/EAP CBI’s Expanded Access Programs 2019 focuses on the design, development and practical implementation of early access programs. The summit convenes top industry stakeholders and regulators to examine current approaches in providing investigational, pre-launch or end-of-lifecycle drugs to patients for treatment purposes. A multi-stakeholder faculty will address key issues affecting EAPs and review the potential impact of the evolving legislative landscape. Drug Channels readers will save $300 off of the standard registration rate when they use code AGK946.* REGISTER TODAY! Join Expert Thought Leaders Including: … Continue reading Expanded Access Programs 2019

Partnering with IDNs BioPharma Strategy Summit West

Partnering with IDNs BioPharma Strategy Summit West March 20-21, 2019 | Scottsdale, AZ www.cbinet.com/IDN As part of an evolving healthcare environment, the life science industry is continually challenged to be effective in how it engages health system partners. It is critical that discussions evolve to meet the needs of today and also where healthcare is headed tomorrow. To address the challenges and opportunities ahead, join a distinguished group of industry pioneers at CBI’s Partnering with IDNs BioPharma Strategy Summit West – an important event for learning how to best meet the needs of these evolving networks for better patient outcomes. … Continue reading Partnering with IDNs BioPharma Strategy Summit West

Shaping an Effective Data and Analytics Strategy for Your Oncology Therapy in 2019

Today’s guest post comes from Derek Rago, VP/GM of Data, Evidence & Insights at McKesson Life Sciences. Derek discusses how biopharma companies can use real-world evidence to gain efficiencies and build effective strategies. He also outlines the key elements of an effective data and analytics strategy. To learn more about McKesson’s data, evidence and insights solutions, visit McKesson.com/DataInsights. Read on for Derek’s insights. Read more » Copyright © 2006-2019 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. This Feed is for personal non-commercial use only.          Powered by WPeMatico Continue reading Shaping an Effective Data and Analytics Strategy for Your Oncology Therapy in 2019

CBI’s 15th Annual Life Sciences Accounting & Reporting Congress

CBI’s 15th Annual Life Sciences Accounting & Reporting Congress March 20-22, 2019 | Loews Philadelphia Hotel | Philadelphia, PA www.cbinet.com/accounting As product pricing and contracting within the channel continues to tangle in complexity, and the gross-to-net “bubble” swells in size, leaders in Finance and Accounting are often at the front lines, making decisions around strategy and reporting. CBI’s 15th Annual Life Sciences Accounting & Reporting Congress, the world’s top event for finance, accounting and business leaders within life sciences, provides the in-depth CPE education and networking with nearly 600 professionals. Visit www.cbinet.com/accounting for further details and to register. Drug Channels … Continue reading CBI’s 15th Annual Life Sciences Accounting & Reporting Congress

CBI’s 6th Annual e-Rx and EHR

CBI’s 6th Annual e-Rx and EHR March 12-13, 2019 | The Inn at Penn | Philadelphia, PA www.cbinet.com/erx CBI’s 6th Annual e-Rx and EHR conference, taking place March 12-13 in Philadelphia, provides tangible takeaways and tailored sessions to help you understand how to maximize e-prescribing and EHR technology engagement. Don’t miss the major key insights from industry thought-leaders as they discuss the challenges with streamlining HCP workflow, refined strategies for educating patients and best practices in coordinating channel integration with EHR platforms. Download the agenda for complete details and register by Friday, February 8, 2019 and receive $300* off the … Continue reading CBI’s 6th Annual e-Rx and EHR

CBI’s 20th Annual Patient Assistance & Access Programs – PAP 2019

CBI’s 20th Annual Patient Assistance & Access Programs – PAP 2019 March 4-6, 2019 | Baltimore, MD www.cbinet.com/pap During a time when copay programs and patient support are under intense scrutiny and underinsurance continues to plague many patients, PAP 2019 convenes over 450 leaders from the patient assistance and product access field (manufacturers, copay foundations, non-profits, free clinics, advocacy organization, hospitals) to prepare you for what’s ahead. Join over 50 distinguished speakers who are prepared to address the legal environment, industry best practices and policy watch-outs related to prescription access and financial assistance. Drug Channels readers save $400 off the … Continue reading CBI’s 20th Annual Patient Assistance & Access Programs – PAP 2019

Three Reasons to Join the Industry-Wide Effort to Speed Time-to-Therapy for Specialty Pharmacy

Today’s guest post comes from Lee Ann Stember, President and CEO of the National Council for Prescription Drug Programs (NCPDP). Lee Ann discusses the crucial importance of getting patients timely access to specialty therapies. She invites Drug Channels readers to participate in NCPDP’s specialty pharmacy work group and its four task groups. Your participation will help establish and refine standards that will benefit patients and all industry participants. It’s simple. Create an account at www.dms.ncpdp.org and then select your preferred task groups. You can also click here to register for upcoming NCPDP meetings. Read on for Lee Ann’s insights and to get more … Continue reading Three Reasons to Join the Industry-Wide Effort to Speed Time-to-Therapy for Specialty Pharmacy